Does EPCORITAMAB-BYSP Cause Decreased appetite? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Decreased appetite have been filed in association with EPCORITAMAB-BYSP. This represents 0.8% of all adverse event reports for EPCORITAMAB-BYSP.
8
Reports of Decreased appetite with EPCORITAMAB-BYSP
0.8%
of all EPCORITAMAB-BYSP reports
4
Deaths
3
Hospitalizations
How Dangerous Is Decreased appetite From EPCORITAMAB-BYSP?
Of the 8 reports, 4 (50.0%) resulted in death, 3 (37.5%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPCORITAMAB-BYSP. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does EPCORITAMAB-BYSP Cause?
Cytokine release syndrome (369)
Diffuse large b-cell lymphoma (206)
Diffuse large b-cell lymphoma refractory (198)
Pyrexia (79)
Immune effector cell-associated neurotoxicity syndrome (77)
Covid-19 (39)
Neutrophil count decreased (35)
Hypogammaglobulinaemia (32)
Platelet count decreased (32)
Cytomegalovirus infection (31)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which EPCORITAMAB-BYSP Alternatives Have Lower Decreased appetite Risk?
EPCORITAMAB-BYSP vs EPERISONE
EPCORITAMAB-BYSP vs EPHEDRINE
EPCORITAMAB-BYSP vs EPINASTINE
EPCORITAMAB-BYSP vs EPINEPHRINE
EPCORITAMAB-BYSP vs EPINEPHRINE\LIDOCAINE